Hospital News and Research

RSS

Different Crohn's disease treatments affect children's gut microbes in distinct ways

Different treatments for Crohn's disease in children affects their gut mi-crobes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

15 Oct 2015

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, announced today that the LEADERS FREE clinical trial demonstrated superior safety and efficacy for BioFreedom compared with a bare-metal stent (BMS).

15 Oct 2015

Researchers link organ transplant drug to rise in rare lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

15 Oct 2015

Intuitive Surgical and Trumpf Medical team up to address hospitals’ need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical’s advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

15 Oct 2015

Rogosin selected to participate in new Comprehensive End-Stage Renal Disease Care Model

The Rogosin Institute, a NYC-based non-profit provider of comprehensive kidney care, including dialysis for patients with end-stage renal disease (ESRD), has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the new Comprehensive End-Stage Renal Disease Care (CEC) Model established by CMMI, CMS's Center for Innovation.

15 Oct 2015

The Medical Center of Plano Partners with BIND, Brain Injury Network of Dallas to support survivors of traumatic brain injuries

Supporting patients who have suffered a serious brain injury is the goal of a new partnership between The Medical Center of Plano and the Brain Injury Network of Dallas, also called BIND.

15 Oct 2015

DePuy Synthes Spine launches new all-in-one pedicle screw system to help simplify spinal surgery

DePuy Synthes Spine has introduced the EXPEDIUM VERSE Spinal System, a new all-in-one pedicle screw system. The system enables surgeons to perform multiple spinal correction maneuvers during spinal fusion surgery with a single implant type and fewer instruments, compared to traditional pedicle screw systems.

15 Oct 2015

Long-term lithium exposure does not increase renal dysfunction risk

Stable lithium maintenance therapy does not increase the risk of renal dysfunction in patients with bipolar affective disorder, findings from a population-based study suggest.

14 Oct 2015

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

14 Oct 2015

Sense oligonucleotide antidote reverses actions of antisense antithrombotic drug, prevents bleeding

Researchers from Isis Pharmaceuticals (Carlsbad, CA) and Prysis Biotechnologies (Pudong, Shanghai, China) have demonstrated proof-of-concept for using a sense oligonucleotide to undo the effects of an antisense drug, an antithrombotic agent in this novel study.

14 Oct 2015

Diabetic patients who use nurse practitioners for primary care have lower rates of preventable hospitalization

New research from The University of Texas Medical Branch at Galveston indicates that diabetic patients who got their primary care from nurse practitioners did not have an increase in potentially preventable hospital admissions.

14 Oct 2015

Insulin dose not independent risk factor for cardiovascular death

A NIH-sponsored double-blinded, randomized clinical trial entitled Action to Control Cardiovascular Risk in Diabetes (ACCORD study) came to a halt seven years ago after patients receiving more intensive diabetes therapy were found to have a higher mortality rate, compared to the standard therapy.

14 Oct 2015

UI Cancer Center and GSU to help reduce cancer-related health disparities in Chicago's south suburbs

The greatest burden of cancer in the Chicago region has moved from the city to the suburbs. The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.

14 Oct 2015

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

VolitionRx Limited today announced that full results from a completed clinical study of its NuQ blood-based test for early stage pancreatic cancers have been published in the online issue of Clinical Epigenetics, the official journal of the Clinical Epigenetics Society.

14 Oct 2015

Drug-resistant E. coli infections on the rise in community hospitals

Drug-resistant E. coli infections are on the rise in community hospitals, where more than half of U.S. patients receive their health care, according to a new study from Duke Medicine.

14 Oct 2015

MIT neuroscientists discover brain circuit that controls sleep

Sleep is usually considered an all-or-nothing state: The brain is either entirely awake or entirely asleep. However, MIT neuroscientists have discovered a brain circuit that can trigger small regions of the brain to fall asleep or become less alert, while the rest of the brain remains awake.

14 Oct 2015

Sleep apnea associated with evidence of early heart injury in women

Risk factors for obstructive sleep apnea (OSA) and the development of subsequent cardiovascular (CV) complications differ by sex, but it is not clear from prior research whether the effects of sleep apnea on heart disease is similar for men and women.

13 Oct 2015

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Today, GENALICE is setting a new standard for ultra-fast and highly reliable detection of all DNA changes in large patient cohorts. In a one-hour online event, the complete genomes of 800 Alzheimer Disease (AD) patients were processed, and by ingeniously using the aggregate information from the complete group, detection of DNA changes, or variants, in individual patients was enhanced.

13 Oct 2015

DePuy Synthes Trauma announces U.S. launch of new biologic implant for trauma-related extremity procedures

DePuy Synthes Trauma announced today the U.S. launch of CONFORM Flex with Q-PACK Technology, the only pre-hydrated demineralized cancellous bone tissue matrix designed for use in trauma-related extremity procedures, including fusion, and for filling bone voids.

13 Oct 2015

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

13 Oct 2015

Hospital News and Research

Different Crohn's disease treatments affect children's gut microbes in distinct ways

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

Researchers link organ transplant drug to rise in rare lymphoma

Intuitive Surgical and Trumpf Medical team up to address hospitals’ need for operating room integration

Rogosin selected to participate in new Comprehensive End-Stage Renal Disease Care Model

The Medical Center of Plano Partners with BIND, Brain Injury Network of Dallas to support survivors of traumatic brain injuries

DePuy Synthes Spine launches new all-in-one pedicle screw system to help simplify spinal surgery

Long-term lithium exposure does not increase renal dysfunction risk

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

Sense oligonucleotide antidote reverses actions of antisense antithrombotic drug, prevents bleeding

Diabetic patients who use nurse practitioners for primary care have lower rates of preventable hospitalization

Insulin dose not independent risk factor for cardiovascular death

UI Cancer Center and GSU to help reduce cancer-related health disparities in Chicago's south suburbs

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

Drug-resistant E. coli infections on the rise in community hospitals

MIT neuroscientists discover brain circuit that controls sleep

Sleep apnea associated with evidence of early heart injury in women

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

DePuy Synthes Trauma announces U.S. launch of new biologic implant for trauma-related extremity procedures

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News